Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients

Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients

While cardiovascular disease has been associated with an increased risk of coronavirus disease 2019 (COVID-19), no studies have described its clinical course in patients with aortic stenosis who had undergone transcatheter aortic valve replacement (TAVR). Numerous observational studies have reported...

Full description

Bibliographic Details
Main Authors: Marion Kibler, Laurent Dietrich, Mohamad Kanso, Adrien Carmona, Benjamin Marchandot, Kensuke Matsushita, Antonin Trimaille, Cécile How-Choong, Albane Odier, Gabrielle Gennesseaux, Ophélie Schramm, Antje Reydel, Sébastien Hess, Chisato Sato, Sophie Caillard, Laurence Jesel, Olivier Morel, Patrick Ohlmann
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
ABO blood group
coronavirus disease 2019
transcatheter aortic valve replacement
Online Access:https://www.mdpi.com/2077-0383/9/11/3769

Internet

https://www.mdpi.com/2077-0383/9/11/3769

Similar Items